Mississauga firms: new WSIB premiums make things worse
New workers compensation fees that kick in next year are going to cost companies thousands of dollars and could force some to hike charges to their own customers
Category: Uncategorized
Experts: Laid off Loblaws workers entering mixed job market
Laid off employees at Loblaws head office in Brampton are entering a job market with solid demand for high-skilled IT workers but they still face many challenges
UTM receives mediocre grades, aims to improve student experience
University of Toronto Mississauga is responding to student complaints with new faculty hires, renovations and expanded programs for undergraduates
Worker compensation board hikes premiums for all businesses for 2013
Companies in Mississauga and Brampton — from large multinationals to small truckers — will have to dig deeper into their pockets to pay higher worker compensation premiums next year
Students give UTM mixed reviews in university survey
The University of Toronto Mississauga made gains in this year’s Canadian University Report published in The Globe and Mail on Tuesday, but still received mixed reviews in the annual undergraduate survey
Loblaw’s ex-employees will need to pound the pavement
Job prospects for Loblaw’s 700 laid off employees are uncertain and heavily dependent on personal efforts, said past Mississauga Technology Association president Adolfo Proietti
Therapure’s new facility in Mississauga creates more jobs than expected
Therapure Biopharma Inc.’s new manufacturing facility has led to more jobs and business interest since its opening in April, said company spokesperson Dina Iezzi
Retailers plan for in-store and online holiday shoppers
Future Shop and Best Buy may be cutting back on seasonal staffing this Christmas, but the allure of going to the store is still very strong
Pill Hill: Biotech drives Mississauga’s economy
Meadowvale’s “Pill Hill” is a cluster of most of the city’s biotechnology, biomedical and other life-science companies
Glaxo ruling benefits Big Pharma companies in Mississauga
A top court ruling that sides with GlaxoSmithKline in the British drug giant’s tax fight case with Ottawa is ‘happy news for Big Pharma,’ a tax law expert tells YourMississaugaBiz.com
Karen K. Ho 